title: Promise of extended-release naltrexone is a red herring.
authors.forename: Gavin
authors.initials: G
authors.lastname: Bart
mesh_terms: D002047:Buprenorphine / Q000008:administration & dosage; D003692:Delayed-Action Preparations; D006801:Humans; D007267:Injections; D008691:Methadone / Q000008:administration & dosage; D009271:Naltrexone / Q000008:administration & dosage*; D009292:Narcotic Antagonists / Q000008:administration & dosage*; D058850:Opiate Substitution Treatment; D009293:Opioid-Related Disorders / Q000534:rehabilitation*; D012426:Russia
chemical_list: D003692:Delayed-Action Preparations; D009292:Narcotic Antagonists; D002047:Buprenorphine; D009271:Naltrexone; D008691:Methadone